Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease

被引:0
作者
E Baskin
US Bayrakci
Konuksever Di
S Turkay
B Varan
H Ercoban
Z Avci
机构
[1] Baskent University,
[2] Fatih University,undefined
关键词
Kawasaki Disease; Subclavian Artery; Conjunctivitis; Left Coronary Artery; Peripheral Blood Smear;
D O I
10.1186/1546-0096-6-S1-P274
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Steroid Pulse Therapy for Children With Intravenous Immunoglobulin Therapy–Resistant Kawasaki Disease: A Prospective Study
    Masayuki Teraguchi
    Hirotaro Ogino
    Ken Yoshimura
    Shoichiro Taniuchi
    Minoru Kino
    Hitoshi Okazaki
    Kazunari Kaneko
    Pediatric Cardiology, 2013, 34 : 959 - 963
  • [42] Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
    Kobayashi, Tohru
    Inoue, Yoshinari
    Takeuchi, Kazuo
    Okada, Yasunori
    Tamura, Kazushi
    Tomomasa, Takeshi
    Kobayashi, Tomio
    Morikawa, Akihiro
    CIRCULATION, 2006, 113 (22) : 2606 - 2612
  • [43] Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
    Cheon, Eun Jung
    Oh, Jun Suk
    BMC PEDIATRICS, 2024, 24 (01)
  • [44] Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease
    Nakamura, Nami
    Muto, Taichiro
    Masuda, Yu
    Numoto, Shingo
    Kodama, Shunsuke
    Miyamoto, Ryosuke
    Miyata, Kenji
    Hayakawa, Tomohito
    Mori, Hiromitsu
    Kuroyanagi, Yoshiyuki
    Akaihata, Mitsuko
    Iwayama, Hideyuki
    Kurahashi, Hirokazu
    Shimomura, Yasuhito
    Nagai, Takuhito
    Hori, Toshinori
    Agata, Hiroatsu
    Okumura, Akihisa
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (09) : 857 - 861
  • [45] The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease
    Asano, Satoshi
    Fukushima, Naoya
    Yamada, Kenichiro
    PEDIATRICS AND NEONATOLOGY, 2024, 65 (05) : 441 - 444
  • [46] Comparison of the Laboratory Data Between Kawasaki Disease and Enterovirus After Intravenous Immunoglobulin Treatment
    Li-Yan Lin
    Tsung-Hsien Yang
    Ying-Jui Lin
    Hong-Ren Yu
    Kuender D. Yang
    Yi-Chuan Huang
    Wei-Chiao Chang
    Ho-Chang Kuo
    Pediatric Cardiology, 2012, 33 : 1269 - 1274
  • [47] Thrombospondin-2 predicts response to treatment with intravenous immunoglobulin in children with Kawasaki disease
    Yang, Shuai
    Song, Ruixia
    Li, Xiaohui
    Zhang, Ting
    Fu, Jin
    Cui, Xiaodai
    BMJ PAEDIATRICS OPEN, 2018, 2 (01)
  • [48] The Validity of a Scoring System in Predicting Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease
    Nateghian, Alireza
    Tafreshi, Roya Isa
    Najari, Arezoo
    Vaezi, Atefeh
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2016, 4 (01):
  • [49] Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
    Bal, Aswine K.
    Prasad, Deepa
    Pamintuan, Maria Angela Umali
    Mammen-Prasad, Elizabeth
    Petrova, Anna
    PEDIATRICS AND NEONATOLOGY, 2014, 55 (05) : 387 - 392
  • [50] FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response
    Makowsky, Robert
    Wiener, Howard W.
    Ptacek, Travis S.
    Silva, Miriam
    Shendre, Aditi
    Edberg, Jeffrey C.
    Portman, Michael A.
    Shrestha, Sadeep
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (09) : 455 - 462